Velagliflozin (proline) structure
|
Common Name | Velagliflozin (proline) | ||
|---|---|---|---|---|
| CAS Number | 1539295-26-5 | Molecular Weight | 510.58 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H34N2O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Velagliflozin (proline)Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations[1]. |
| Name | Velagliflozin (proline) |
|---|
| Description | Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Velagliflozin (1 mg/kg, 口服, 单剂量) proline 增加胆固醇、白蛋白、β -羟基丁酸 (BHB)、非酯化脂肪酸 (NEFA) 和尿葡萄糖排泄,并降低猫的呼吸交换比率[1]。 Velagliflozin (0.3 mg/kg; 口服; 每天 1 次, 共 18 天) proline 耐受性良好,可通过降低饮食非结构性碳水化合物 (NSC) 的高胰岛素反应来治疗小马的胰岛素失调和预防椎板炎[2]。 |
| References |
| Molecular Formula | C28H34N2O7 |
|---|---|
| Molecular Weight | 510.58 |
| InChIKey | UWKBFNWQMSGEPG-ZHNCTCHCSA-N |
| SMILES | N#Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(C2CC2)cc1.O=C(O)C1CCCN1 |